SOLID-TIMI 52 was a multinational , double-blind , placebo-controlled trial that randomized 13,026 participants within 30 days of hospitalization with an ACS ( non-ST-elevation or ST-elevation myocardial infarction [ MI ] ) at 868 sites in 36 countries .